Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.
暂无分享,去创建一个
H Robert Bergen | David C Muddiman | H. R. Bergen | John C Burnett | Adam M. Hawkridge | D. Muddiman | J. Burnett | A. Cataliotti | Alessandro Cataliotti | Adam M Hawkridge | Denise M Heublein | D. Heublein
[1] M. Kosmulski,et al. Multiinstrument study of the electrophoretic mobility of fumed silica. , 2002, Analytical chemistry.
[2] R. Aebersold,et al. Mass spectrometry-based proteomics , 2003, Nature.
[3] A. Richards,et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.
[4] N. Anderson,et al. The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.
[5] R. Aebersold,et al. Mass spectrometry in proteomics. , 2001, Chemical reviews.
[6] G. Baxter. The natriuretic peptides , 2004, Basic Research in Cardiology.
[7] T. LeJemtel,et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. , 2000, The New England journal of medicine.
[8] O. Vuolteenaho,et al. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. , 2004, Clinical chemistry.
[9] Alan S Maisel,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.
[10] Fred W. McLafferty,et al. High-resolution tandem FT mass spectrometry above 10 kDa , 1994 .
[11] H. Imura,et al. Hemodynamic, Renal, and Hormonal Responses to Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure , 1991, Circulation.
[12] Naoto Minamino,et al. A new natriuretic peptide in porcine brain , 1988, Nature.
[13] H. R. Bergen,et al. Dual electrospray ionization source for confident generation of accurate mass tags using liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry. , 2003, Analytical chemistry.
[14] J. Goetze. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. , 2004, Clinical chemistry.
[15] M. Bolgar,et al. Degradation of brain natriuretic peptide by neutral endopeptidase: species specific sites of proteolysis determined by mass spectrometry. , 1991, Biochemical and biophysical research communications.
[16] L. Wallentin,et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. , 2004, Clinical chemistry.
[17] M. Tamaki,et al. Molecular forms of human brain natriuretic peptide in plasma. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[18] K. Bailey,et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. , 1996, Hypertension.
[19] A. Maisel. The Diagnosis of Acute Congestive Heart Failure: Role of BNP Measurements , 2003, Heart Failure Reviews.
[20] A. Jaffe,et al. Quality specifications for B-type natriuretic peptide assays. , 2005, Clinical chemistry.
[21] A. Marshall,et al. Fourier transform ion cyclotron resonance mass spectrometry: a primer. , 1998, Mass spectrometry reviews.
[22] N. Kennedy,et al. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. , 1996, The American journal of cardiology.
[23] U. Janssens,et al. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. , 2001, Clinical chemistry.
[24] T. Ogihara,et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. , 1992, Biochemical and biophysical research communications.
[25] E. Espiner,et al. The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. , 1999, Biochemical and biophysical research communications.
[26] K. Sugita,et al. Characterization of molecular forms of probrain natriuretic peptide in human plasma. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[27] L. Lenert,et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.
[28] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[29] M. Sabatine,et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.
[30] H. Hense,et al. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population , 2000, Journal of hypertension.